From trying to create new cartilage in the laboratory to clinical trials for patients with brain injuries, scientists and physicians at The University of Texas Health Science Center at Houston (UTHealth) are leading the way in stem cell research.
In partnership with Memorial Hermann-Texas Medical Center, UTHealth was the first in the country to intravenously inject a stroke patient’s own stem cells in a trial funded by the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health. Learn how researchers continue to push the boundaries of this promising field.
Bone marrow stem cells do not improve short-term recovery after heart attack
Administering stem cells derived from patients’ own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health (NIH).
Continue reading »Safety results of intra-arterial stem cell clinical trial for stroke presented
Early results of a Phase II intra-arterial stem cell trial for ischemic stroke showed no adverse events associated with the first 10 patients, allowing investigators to expand the study to a targeted total of 100 patients.
Continue reading »UTHealth neurologist Sean I. Savitz, M.D., honored for stroke work
Sean I. Savitz, M.D., associate professor of neurology at The University of Texas Health Science Center at Houston (UTHealth), recently received the Molly and Bernard Sanberg Memorial Award from the American Society of Neural Therapy and Repair (ASNTR).
Continue reading »Related Stories and Helpful Information
- UTHealth enrolls first patient in stem cell therapy trial for acute stroke
- UT is the only TMC institution selected for stem cell clinical trial
- UTHealth reports stem cell therapy safe for acute stroke
- UTHealth Stem Cell Research
- UT Physicians, Neurology, 832.325.7080
